MIM
RMD icon

Morningstar Investment Management’s ResMed RMD Stock Holding History

Morningstar Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-786
Closed -$215K – 441
2025
Q3 		$215K Buy
+786
New +$215K 0.01% 467

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Morningstar Investment Management's RMD Position: Q4 2025 in Review

Morningstar Investment Management sold out of ResMed (RMD) in Q4 2025, closing a stake of 786 shares — an estimated $215K sold.

Morningstar Investment Management first reported a position in RMD in Q3 2025 and held it in 1 quarter. The position peaked at $215K in Q3 2025. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Morningstar Investment Management reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Morningstar Investment Management sold 786 ResMed shares in Q4 2025, an estimated $215K.
  • Morningstar Investment Management first reported a position in ResMed in Q3 2025 and held it in 1 quarter.
  • Morningstar Investment Management's ResMed position peaked at $215K in Q3 2025.
  • 948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Morningstar Investment Management's 13F filing for Q4 2025, filed 9 Feb 2026.